20.62% | % of shares held by all insiders |
65.67% | % of shares held by institutions |
82.74% | % of float held by institutions |
347 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
QVT Financial LP | 112,541,536 | 31 Dec 2023 | 13.97% | 1,131,605,178 |
SB Investment Advisers (UK) LTD | 73,031,667 | 31 Dec 2023 | 9.06% | 734,333,433 |
Viking Global Investors, L.P. | 69,368,961 | 31 Dec 2023 | 8.61% | 697,504,924 |
Blackrock Inc. | 36,187,519 | 31 Mar 2024 | 4.49% | 363,865,514 |
FMR, LLC | 35,340,563 | 31 Mar 2024 | 4.39% | 355,349,371 |
Morgan Stanley | 21,927,044 | 31 Dec 2023 | 2.72% | 220,476,434 |
Rubric Capital Management LP | 20,000,000 | 31 Mar 2024 | 2.48% | 201,100,006 |
State Street Corporation | 13,727,418 | 31 Dec 2023 | 1.70% | 138,029,192 |
Wellington Management Group, LLP | 13,640,416 | 31 Dec 2023 | 1.69% | 137,154,387 |
Patient Square Capital LP | 12,228,465 | 31 Mar 2024 | 1.52% | 122,957,219 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Fidelity Growth Company Fund | 10,865,857 | 31 Mar 2024 | 1.35% | 109,256,195 |
iShares Core S&P Midcap ETF | 10,506,573 | 31 Mar 2024 | 1.30% | 105,643,594 |
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 7,192,287 | 31 Mar 2024 | 0.89% | 72,318,447 |
Vanguard Extended Market Index Fund | 4,945,664 | 31 Dec 2023 | 0.61% | 49,728,653 |
Morgan Stanley Inst Fd Inc-Growth Port | 4,130,061 | 31 Dec 2023 | 0.51% | 41,527,764 |
Fidelity Select Portfolios - Biotechnology | 3,856,619 | 31 Mar 2024 | 0.48% | 38,778,305 |
iShares Biotechnology ETF | 3,612,345 | 31 Mar 2024 | 0.45% | 36,322,130 |
Fidelity Growth Company K6 Fund | 3,528,158 | 31 Mar 2024 | 0.44% | 35,475,629 |
Fidelity Series Growth Company Fund | 2,731,200 | 31 Mar 2024 | 0.34% | 27,462,216 |
Fidelity Extended Market Index Fund | 1,948,268 | 31 Mar 2024 | 0.24% | 19,589,835 |